|
TTD
Drug ID:
DPR000162
Drug
Information |
Name | YM-992 | Synonyms | YM-35992; Lubazodone hydrochloride; YM992; Morpholine, 2-(((7-fluoro-2,3-dihydro-1H-inden-4-yl)oxy)methyl)-, hydrochloride (2S)-; (S)-2-(((7-fluoro-4-indanyl)oxy)methyl)morpholine hydrochloride; UNII-2KT2C544LR; Lubazodone HCl; D04788; Lubazodone hydrochloride; AC1L4IXB; Lubazodone hydrochloride [USAN]; (2S)-2-[(7-fluoro-2,3-dihydro-1H-inden-4-yl)oxymethyl]morpholine hydrochloride; SM-50C; CID157918; 161178-10-5; Lubazodone hydrochloride (USAN) | Trade Name | Lubazodone | Company | Yamanouchi | Indication | Depression | Discontinued in Phase II | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | Therapeutic Class | Psychiatric | PubChem Compound ID | CID 157918. | PubChem Substance ID | SID 735349. | Target | 5-HT2A receptor |  | Inhibitor | [1] | Serotonin transporter |  | Inhibitor | [1] | Ref 1 | Curr Top Med Chem. 2006;6(17):1801-23.Serotonin reuptake inhibitors: the corner stone in treatment of depression for half a century--a medicinal chemistry survey. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|